143 related articles for article (PubMed ID: 28862295)
1. Synthesis of Some Substituted 6-Phenyl Purine Analogues and Their Biological Evaluation as Cytotoxic Agents.
Kucukdumlu A; Tuncbilek M; Bilget Guven E; Cetin Atalay R
Acta Chim Slov; 2017 Sep; 64(3):621-632. PubMed ID: 28862295
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis and In Vitro Cytotoxic Activity of New 6,9-Disubstituted Purine Analogues.
Kucukdumlu A; Tuncbilek M; Guven EB; Atalay RC
Acta Chim Slov; 2020 Mar; 67(1):70-82. PubMed ID: 33558921
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel substituted purine derivatives and identification of the cell death mechanism.
Demir Z; Guven EB; Ozbey S; Kazak C; Atalay RC; Tuncbilek M
Eur J Med Chem; 2015 Jan; 89():701-20. PubMed ID: 25462277
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel 6-substituted amino-9-(β-d-ribofuranosyl)purine analogs and their bioactivities on human epithelial cancer cells.
Tuncbilek M; Kucukdumlu A; Guven EB; Altiparmak D; Cetin-Atalay R
Bioorg Med Chem Lett; 2018 Feb; 28(3):235-239. PubMed ID: 29326016
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel 6-(4-substituted piperazine-1-yl)-9-(β-D-ribofuranosyl)purine derivatives, which lead to senescence-induced cell death in liver cancer cells.
Tuncbilek M; Guven EB; Onder T; Cetin Atalay R
J Med Chem; 2012 Apr; 55(7):3058-65. PubMed ID: 22409771
[TBL] [Abstract][Full Text] [Related]
6. Regiospecific microwave-assisted synthesis and cytotoxic activity against human breast cancer cells of (RS)-6-substituted-7- or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H- or -9H-purines.
Conejo-García A; Núñez MC; Marchal JA; Rodríguez-Serrano F; Aránega A; Gallo MA; Espinosa A; Campos JM
Eur J Med Chem; 2008 Aug; 43(8):1742-8. PubMed ID: 18069093
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and anticancer activity against the MCF-7 cell line of benzo-fused 1,4-dihetero seven- and six-membered tethered pyrimidines and purines.
Núñez MC; Díaz-Gavilán M; Conejo-García A; Cruz-López O; Gallo MA; Espinosa A; Campos JM
Curr Med Chem; 2008; 15(25):2614-31. PubMed ID: 18855682
[TBL] [Abstract][Full Text] [Related]
8. N9-Substituted N⁶-[(3-methylbut-2-en-1-yl)amino]purine derivatives and their biological activity in selected cytokinin bioassays.
Mik V; Szüčová L; Spíchal L; Plíhal O; Nisler J; Zahajská L; Doležal K; Strnad M
Bioorg Med Chem; 2011 Dec; 19(23):7244-51. PubMed ID: 22019467
[TBL] [Abstract][Full Text] [Related]
9. Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies.
Díaz-Gavilán M; Gómez-Vidal JA; Rodríguez-Serrano F; Marchal JA; Caba O; Aránega A; Gallo MA; Espinosa A; Campos JM
Bioorg Med Chem Lett; 2008 Feb; 18(4):1457-60. PubMed ID: 18194866
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anticancer activity of novel C6-piperazine substituted purine steroid-nucleosides analogues.
Huang LH; Xu HD; Yang ZY; Zheng YF; Liu HM
Steroids; 2014 Apr; 82():1-6. PubMed ID: 24378780
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and anticancer activity of (RS)-9-(2,3-dihydro-1,4-benzoxaheteroin-2-ylmethyl)-9H-purines.
Conejo-García A; García-Rubiño ME; Marchal JA; Núñez MC; Ramírez A; Cimino S; García MÁ; Aránega A; Gallo MA; Campos JM
Eur J Med Chem; 2011 Sep; 46(9):3795-801. PubMed ID: 21645946
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and screening of 6-alkoxy purine analogs as cell type-selective apoptotic inducers in Jurkat cells.
Lorente-Macías Á; Iañez I; Jiménez-López MC; Benítez-Quesada M; Torres-Rusillo S; Díaz-Mochón JJ; Molina IJ; Pineda de Las Infantas MJ
Arch Pharm (Weinheim); 2021 Oct; 354(10):e2100095. PubMed ID: 34128249
[TBL] [Abstract][Full Text] [Related]
13. Anticancer activity and cDNA microarray studies of a (RS)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl]-6-chloro-9H-purine, and an acyclic (RS)-O,N-acetalic 6-chloro-7H-purine.
Caba O; Díaz-Gavilán M; Rodríguez-Serrano F; Boulaiz H; Aránega A; Gallo MA; Marchal JA; Campos JM
Eur J Med Chem; 2011 Sep; 46(9):3802-9. PubMed ID: 21684047
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of new substituted thioglycolurils, their analogues and derivatives.
Gazieva GA; Anikina LV; Nechaeva TV; Pukhov SA; Karpova TB; Popkov SV; Nelyubina YV; Kolotyrkina NG; Kravchenko AN
Eur J Med Chem; 2017 Nov; 140():141-154. PubMed ID: 28923382
[TBL] [Abstract][Full Text] [Related]
15. Benzodiazepine receptor binding activity of 8-substituted-9-(3-substituted-benzyl)-6-(dimethylamino)-9H-purines.
Kelley JL; McLean EW; Linn JA; Krochmal MP; Ferris RM; Howard JL
J Med Chem; 1990 Jan; 33(1):196-202. PubMed ID: 1967311
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic activities of nucleoside and nucleobase analog drugs in malignant mesothelioma: characterization of a novel nucleobase transport activity.
Damaraju D; Damaraju VL; Brun M; Mowles D; Kuzma M; Berendt RC; Sawyer MB; Cass CE
Biochem Pharmacol; 2008 May; 75(10):1901-11. PubMed ID: 18371936
[TBL] [Abstract][Full Text] [Related]
17. Anti-proliferative activity of 2,6-dichloro-9- or 7-(ethoxycarbonylmethyl)-9H- or 7H-purines against several human solid tumour cell lines.
Morales F; Ramírez A; Conejo-García A; Morata C; Marchal JA; Campos JM
Eur J Med Chem; 2014 Apr; 76():118-24. PubMed ID: 24583351
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 2,6-Diamino-Substituted Purine Derivatives and Evaluation of Cell Cycle Arrest in Breast and Colorectal Cancer Cells.
Bosco B; Defant A; Messina A; Incitti T; Sighel D; Bozza A; Ciribilli Y; Inga A; Casarosa S; Mancini I
Molecules; 2018 Aug; 23(8):. PubMed ID: 30103421
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, cell growth inhibition, and antitumor screening of 2-(p-n-butylanilino)purines and their nucleoside analogues.
Wright GE; Dudycz LW; Kazimierczuk Z; Brown NC; Khan NN
J Med Chem; 1987 Jan; 30(1):109-16. PubMed ID: 3806587
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological properties of C-2, C-8, N-9 substituted 6-(3-chloroanilino)purine derivatives as cyclin-dependent kinase inhibitors. Part II.
Oh CH; Kim HK; Lee SC; Oh C; Yang BS; Rhee HJ; Cho JH
Arch Pharm (Weinheim); 2001 Nov; 334(11):345-50. PubMed ID: 11822171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
